HKExAccording to the official website, Broncus has successfully passed the listing hearing of the HKEx.Goldman Sachs Group、Haitong InternationalAs its co-sponsor. Founded in 2012, Drumbo Medical is a pioneer in the field of interventional respiratory medicine, providing innovative lung disease solutions in China and around the world. China's interventional respiratory navigation equipment market mainly includes four major companies, including Broncus. Up to 2018, 2019 and 2020, Broncus ranks first in terms of sales volume in China's interventional respiratory navigation equipment market, with a market share of 43.2%.

It is reported that Broncus announced in March 2018 that the world's largest medical robot companyIntuitive SurgicalLeonardo da Vinci, a maker of surgical robots, has completed a $15 million strategic investment in Broncus, and the two sides have officially become strategic partners. The two sides will jointly develop a surgical robot system based on accurate navigation for the treatment of early lung cancer, and maintain comprehensive and in-depth cooperation in technology sharing, product development and market access.

In addition, it is reported that Fanbo Medical has gone through several rounds of financing before submitting its application, and its investors include QiMing Venture Partners, Intuitive Surgical, Fangyuan Capital, Qingchi Capital, Baidu, Inc. Capital, Xinyin Investment, Dehong Capital, ACM and so on. The IPO fundraising of Trumbo Healthcare will mainly be used to allocate to core products, to fund the expansion of the production line of the plant, to finance the continued expansion of the product portfolio through potential acquisitions, and for general corporate purposes.